Drug intelligence / Profile preview

balanol analog 1

Development stage
Preclinical
Modality
Small Molecules
Administration
Not Specified (experimental; Likely In Vitro Or Ex Vivo Use)[4]
01

Overview

Balanol Analog 1 is a synthetic small molecule derivative of balanol, a fungal metabolite known for its potent inhibition of serine/threonine protein kinases. This analog has been specifically designed to enhance selectivity and potency against cyclic adenosine monophosphate-dependent protein kinase (PKA) over calcium- and phospholipid-dependent protein kinase (PKC). Structural studies show that it binds to the catalytic domain of PKA, stabilizing an intermediate conformation of the Gly-rich loop and disengaging key phosphoryl transfer residues. The compound acts as a competitive inhibitor at the ATP-binding site of these kinases. Its chemical formula is C20H22N2O5[2][3][4][5]. It remains an experimental drug candidate with no approved clinical indications.

Other names
Balanol Analog 1PD007822PD-007822PD 007822B1LB-1LB 1L
02

Targets

PKC (Protein kinase C family)PKA (Cyclic amp-dependent protein kinase)

Beyond the preview

Go deeper on balanol analog 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on balanol analog 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call